\
            
             &
            
        
    
            Contact us
        
Partnership website: https://www.futurefoodspartnership.eu/
The Future Foods partnership will coordinate, align, and leverage European and national R&I efforts to future-proof food systems for co-benefits and provide solutions to the Farm to Fork strategy. The objective of the partnership is to collectively develop and implement an EU-wide committed research and innovation partnership to accelerate the transition towards healthy diets that are safe and sustainably produced, and consumed in resilient EU and global food systems.
Contact
Commission services: Daniela Lueth
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
                                                                            
                        pascal.verheye@vlaio.be
                        
                    The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.